David C. Dalgarno
25Patents
10h-index
30Co-inventors
75Inventor score
Filing activity: Dec 18, 2000 → Aug 31, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8114874B2 | Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors | Chemistry; Metallurgy | 37 | Active |
| US6420384B2 | Proton pump inhibitors | Chemistry; Metallurgy | 26 | Expired |
| US9012462B2 | Phosphorous derivatives as kinase inhibitors | Chemistry; Metallurgy | 23 | Active |
| US8071609B2 | Unsaturated heterocyclic derivatives | Human Necessities | 20 | Active |
| US8278307B2 | Monocyclic Heteroaryl compounds | Chemistry; Metallurgy | 20 | Active |
| US8461167B2 | Acetylenic heteroaryl compounds | Chemistry; Metallurgy | 14 | Active |
| US8470851B2 | Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors | Chemistry; Metallurgy | 13 | Active |
| US8586566B2 | Unsaturated heterocyclic derivatives | Human Necessities | 11 | Active |
| US8778942B2 | Substituted acetylenic imidazo[1,2-A]pyrazine compounds as kinase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US9029533B2 | Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US9273077B2 | Phosphorus derivatives as kinase inhibitors | Chemistry; Metallurgy | 10 | Active |
| US9090561B2 | Acetylenic heteroaryl compounds | Chemistry; Metallurgy | 9 | Active |
| US9278971B2 | Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors | Chemistry; Metallurgy | 9 | Active |
| US8912330B2 | Azaindole derivatives as kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9796712B2 | Heteroaryl compounds for kinase inhibition | Chemistry; Metallurgy | 4 | Active |
| US7115589B2 | Purine derivatives | Chemistry; Metallurgy | 3 | Expired |
| US9834521B2 | Choline kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9834571B2 | Compounds for inhibiting cell proliferation in EGFR-driven cancers | Chemistry; Metallurgy | 2 | Active |
| US9834518B2 | Compounds for inhibiting cell proliferation in EGFR-driven cancers | Chemistry; Metallurgy | 2 | Active |
| US10227342B2 | Heteroaryl compounds for kinase inhibition | Chemistry; Metallurgy | 2 | Active |
| US8496967B2 | Oral formulations | Human Necessities | 1 | Active |
| US11001580B2 | Aminothiazole compounds as c-Kit inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11958850B2 | Heteroaryl compounds for kinase inhibition | Chemistry; Metallurgy | 0 | Active |
| US11117883B2 | Benzimidazole compounds as c-Kit inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11753404B2 | Aminothiazole compounds as c-Kit inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.